Bauckneht, Matteo https://orcid.org/0000-0002-1937-9116
Checcucci, Enrico
Cisero, Edoardo
Rizzo, Alessio
Racca, Manuela
De Cillis, Sabrina
Amparore, Daniele
De Luca, Stefano
Fiori, Cristian
Rescigno, Pasquale
Porpiglia, Francesco
Article History
Received: 1 September 2023
Accepted: 21 October 2023
First Online: 8 November 2023
Declarations
:
: The study was conducted following the Declaration of Helsinki and performed within our clinical trial on oligometastatic prostate cancer patients approved by the local ethical committee (protocol number 017-FPO19).
: All patients provided written informed consent at the time of imaging.
: Matteo Bauckneht reports personal fees from AAA and General Electric Healthcare outside the submitted work. The other authors do not report any conflict of interest.